FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 54 filers reported holding FORTRESS BIOTECH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,742 | -47.2% | 6,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,300 | -34.0% | 6,000 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $5,000 | -37.5% | 6,000 | +20.0% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | -46.7% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $15,000 | -34.8% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $23,000 | +15.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $20,000 | -9.1% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $22,000 | -8.3% | 5,000 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $24,000 | +26.3% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $19,000 | +35.7% | 5,000 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $14,000 | -6.7% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $15,000 | +15.4% | 5,000 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $13,000 | -18.8% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $16,000 | +14.3% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $14,000 | +7.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $13,000 | -23.5% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $17,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,887,500 | $12,323,000 | 1.61% |
| Nantahala Capital Management | 8,680,909 | $27,518,000 | 0.85% |
| SHIKIAR ASSET MANAGEMENT INC | 558,500 | $1,770,000 | 0.64% |
| CPWM, LLC | 506,267 | $1,605,000 | 0.15% |
| Sandbox Financial Partners, LLC | 14,650 | $46,000 | 0.04% |
| Sepio Capital, LP | 134,748 | $427,000 | 0.04% |
| 683 Capital Management, LLC | 200,000 | $635,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 22,928 | $73,000 | 0.01% |
| Virtu Financial LLC | 33,333 | $106,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 55,510 | $176,000 | 0.01% |